• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Reinforcing Omega-3 Supply Networks

    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Women's Health Brand O Positiv Launches Essentials Line of Supplements

    Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Trust Transparency Consulting

    Bioenergy Life Science, Inc. (BLS)

    Premium Labels & Packaging Solutions

    Applied Food Sciences, Inc.

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Trust Transparency Consulting

    Bioenergy Life Science, Inc. (BLS)

    Premium Labels & Packaging Solutions

    Applied Food Sciences, Inc.

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Can a Simple Vitamin E Keep Cardiometabolic Syndrome at Bay?

    Research continues to write the success story of tocotrienol.

    Can a Simple Vitamin E Keep Cardiometabolic Syndrome at Bay?
    By Anne Trias, MS, American River Nutrition03.02.22
    Cardiometabolic syndrome, recognized as a disease entity by the World Health Organization, is a complex combination of metabolic and cardiovascular dysfunctions.1,2 Among lifestyle changes such as revamped diets and exercise schedules, dietary supplements provide adjunctive relief for many of the risk factors associated with the syndrome.

    Vitamin E—known as a universal antioxidant—has been trialed variously in support of cardiometabolic health, often with conflicting and disappointing results.3 Without regard to its isomeric diversity, many have turned their back on vitamin E and its potential benefits for heart and metabolic health. Emerging clinical research, however, suggests tocotrienols to be far superior to their tocopherol cousins in providing cardiometabolic relief.

    Vitamin E Unriddled
    Everyone is familiar with vitamin E, but few are aware that the term encompasses an entire family of distinct, albeit related, compounds. Vitamin E in the form of alpha-tocopherol celebrates its 100th birthday in 2022, marking its discovery as an essential component to fetal development a century ago.

    Lagging behind its cousin, tocotrienol entered the research field approximately 50 years later, but remained shrouded in mystery until commercialization of the first supplements in the 1990s. Bearing similar molecular structures headed by a chromanol ring, both tocopherols and tocotrienols are potent antioxidants. 

    What differentiates tocotrienols is a flexible unsaturated farnesyl tail, which has been credited with superior efficacy in a variety of functions. Tocotrienols, like all vitamin E compounds, are fat-soluble and occur naturally in oil-based components of vegetation like seeds and nuts, where the plant utilizes the antioxidant’s radical scavenging properties to fend off stressors such as the sun’s radiating ultraviolet rays.

    An example of this type of protection occurs in the annatto plant, one of the prime sources of tocotrienols, and the only one known to provide exclusively delta- and gamma-tocotrienol isomers, thought to be most potent for the majority of applications. Annatto supplies the carotenoid bixin, a prominent natural food colorant, and the tocotrienol synthesized by the plant provides oxidative protection to preserve its color.

    Other major sources of tocotrienols include palm and rice bran, but these contain significant amounts of alpha-tocopherol. Sadly, the notion of “the more the merrier” does not apply to mixing of vitamin E isomers, even when they occur together naturally. Research has shown that if alpha-tocopherol contributes more than 10% to the total vitamin E composition, tocotrienol functions and benefits are hampered.4

    With palm and rice tocotrienols containing 25-50% of alpha-tocopherol, respectively, it is easy to see why several clinical trials exploring the supplements’ cardiometabolic benefits yielded lackluster results.5-7

    Conversely, studies testing tocopherol-free annatto tocotrienol (DeltaGold) achieved significant improvements in patients with cardiometabolic conditions, including cardiovascular disease, prediabetes, diabetes, and fatty liver disease.

    Restoring the Heart
    Every 36 seconds. That’s how often a person in the U.S. succumbs to heart-related ailments. Heart disease remains the leading cause of death in U.S. adults, with nearly 700,000 deaths annually, and an economic disease burden of $363 billion, according to the CDC. Dysfunctional levels of cholesterol go hand-in-hand with inflammation to increase the risk of cardiovascular disease in an already vulnerable population impacted by stress and obesity.

    In the mid-1980s, USDA researchers identified a component with cholesterol-inhibiting properties. Isolated from barley, it soon became known that the hypocholesterolemic compound was tocotrienol, differentiated from tocopherols by only three double bonds in the molecule’s side chain that were essential for the inhibition of cholesterogenesis.8

    Tocotrienol’s hypocholesterolemic mechanism was later confirmed in lab tests conducted by then statin-maker Bristol Myers Squibb, as well as researchers at UT Southwestern, which also houses the lab of Nobel Laureates Michael Brown and Joseph Goldstein (famous for discovering the LDL receptor).9,10 Following numerous successful cell line and animal studies, clinical trials were put into motion to confirm annatto tocotrienol’s heart health benefits.

    Annatto tocotrienol (DeltaGold) was found to balance dyslipidemia after just 4 weeks in patients with elevated cholesterol levels. Although various doses between 125 mg and 750 mg were tested, daily supplementation with 250 mg was observed to be optimal, and reduced LDL, total cholesterol, and triglycerides by 18%, 15%, and 14%, respectively.11

    Dyslipidemia’s silent accomplice in heart disease is a normal immune response turned deviant. Chronic inflammation occurs when the body’s response to fighting foreign invaders transitions to an unrelenting low-grade presence of inflammatory markers that irritate arteries. In a clinical study, annatto tocotrienol was found to tackle chronic inflammation through significant reduction in key inflammatory markers.12 Hypercholesterolemic patients experienced a drop of 40% in C-reactive protein (hs-CRP), with cytokines common in cardiovascular disease—including TNF-alpha and interleukin-6—being downregulated significantly when taking daily supplements of 250 mg tocotrienol (DeltaGold).11,12

    Intervening Diabetes
    Affecting more than a third of the U.S. population, metabolic syndrome—comprising an array of risk factors that include excess body fat, dyslipidemia, high blood pressure, and sugar imbalances—is indelibly linked to heart disease and type 2 diabetes mellitus (T2DM).

    Overlapping with metabolic syndrome is prediabetes, a state of hyperglycemia that is marked by impaired fasting glucose and glucose tolerance, along with glycosylated hemoglobin levels in the range of 5.7-6.4%. A sizable portion of the prediabetes population also has metabolic syndrome, which can be considered a diabetic state, since those with the syndrome have a 5-fold increased risk of developing diabetes.13 Alarmingly, prediabetes has been found to convert to T2DM at an annual rate of 5-10%.14

    Tocotrienols, in part due to their sweeping antioxidant and anti-inflammatory properties, are able to address a wide spectrum of metabolic imbalances. In a clinical trial on prediabetic patients with hallmark elevated HbA1c, DeltaGold annatto tocotrienol was able to reduce the sugar-linked biomarker to nearly the normal range at 5.77%.14 Moreover, patients treated with tocotrienols saw a 4.3% improvement in fasting blood glucose, 11.2% decrease in insulin, and a 15.1% reduction in the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), a method used to quantify insulin resistance. The placebo group had no such decreases, and noticed an increase in HbA1c rather than improvement.14

    Beyond prediabetes, T2DM is a condition where cells respond poorly to key sugar regulator insulin, leading to insulin resistance that blocks sugar from entering cells. The resultant high blood sugar levels eventually give rise to serious health conditions, including cardiovascular, kidney, neurological, and eye diseases. Extending its benefits to diabetes, annatto tocotrienol (DeltaGold) was shown to improve glycemic control in two separate clinical trials of patients with T2DM.

    One 24-week study followed 110 T2DM patients taking either 250 mg tocotrienol or a placebo, where the supplement caused a significant reduction of HbA1c from 8.3-7.8%.15 The HbA1c threshold at which diabetes complications can be delayed or prevented is 7%. Whereas inflammatory biomarker C-reactive protein (hs-CRP) increased in the placebo group, patients receiving tocotrienols found their CRP levels reduced by 10%. Fasting blood glucose, insulin, and HOMA-IR also decreased by 6.8%, 7.6%, and 13.1%, respectively in the treated group. Furthermore, triglycerides, elevated levels of which often precede hyperglycemia, dropped a significant 10.3% in those taking tocotrienol.15

    Higher doses of annatto tocotrienol in T2DM patients work, but are not necessary to elicit a superior response. A similar 24-week study in 120 T2DM patients receiving 500 mg of the supplement or placebo resulted in reductions equal to those of subjects given 250 mg, leading to drops in HbA1c (8.4% to 7.8%), hs-CRP (12%), fasting blood glucose (7%), insulin (9%), and HOMA-IR (14%).16 The study tested additional inflammatory and oxidative stress biomarkers, resulting in 14% and 11% reductions in TNF-alpha and malondialdehyde, respectively.16

    Soothing Liver Inflammation
    When cardiometabolic syndrome is left untended, rampant triglyceride accumulation and insulin resistance can progress to excess hepatic fat storage, resulting in a condition known as non-alcoholic fatty liver disease (NAFLD). The National Institutes of Health estimates NAFLD to affect 30-40% of U.S. adults; in 20% of patients it can transition to advanced non-alcoholic steatohepatitis (NASH) with complications including liver scarring, cirrhosis, and liver cancer.

    In two clinical trials, annatto tocotrienol supplementation produced compelling benefits for NAFLD patients.17,18 In one study, patients received daily supplements of 600 mg annatto tocotrienol for 12 weeks, and in a second study the same dosage was administered for 24 weeks. An unexpected finding of both studies was an observed weight loss of 4.4 kg to 6.8 kg for 12- and 24-week supplementation courses, respectively. In addition, there were significant declines in triglyceride levels (11-13%), C-reactive protein (18-21%), oxidative stress marker malondialdehyde (14-19%), serum amino transferases (15-21%), and fatty liver index score (11-15%).

    While both studies measured the basic biomarkers of fatty liver disease, the 24-week trial yielded further results, including benefits for critical adipose tissue hormones adiponectin and leptin. Patients given annatto tocotrienol experienced an increase in adiponectin by 44%, which is indicative of better fatty acid breakdown and glucose control. These patients also saw an 18% drop in leptin, a sign of diminishing inflammation, and a 15% reduction in HOMA-IR.

    At the completion of the 24-week trial, patients who received 600 mg annatto tocotrienols were three times as likely to see a 1-degree to 2-degree reduction in hepatic steatosis.18 Although several organizations, including the American Association for the Study of Liver Disease, recognize vitamin E in the form of alpha-tocopherol as a potential short-term treatment option for non-diabetic adults with biopsy-proven NASH, improvements in liver biochemistries and histology are modest.19 Conversely, the notable enhancements of liver biomarkers and steatosis reversal clinically observed with tocotrienol supplementation may set a new standard for vitamin E hepatic benefits.

    (Re-)Achieving Prestige
    Vitamin E’s reputation has been debated within the scientific community, a sentiment that has been amplified through the lenses of popular and trade media reporting. Educating consumers about the divergence of vitamin E molecules and tocotrienol’s promising functions is a challenging but worthy cause. Captured in multiple clinical trials, tocotrienol’s cardiometabolic benefits truly embody a success story that’s just waiting to be told. 

    References
    1. Castro, J.P., et al., Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep, 2003. 5(5): p. 393-401.
    2. Srivastava, A.K., Challenges in the treatment of cardiometabolic syndrome. Indian J Pharmacol, 2012. 44(2): p. 155-6.
    3. Ziegler, M., et al., Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy? Antioxidants (Basel), 2020. 9(10).
    4. Trias, AM and Tan, B. Alpha-Tocopherol: A Detriment to Tocotrienol Benefits, in Tocotrienols: Vitamin E Beyond Tocopherols, 2nd ed., B. Tan, R. Watson, and V. Preedy, Editors. 2013, CRC Press: Boca Raton. p. 61-78.
    5. Heng, K.S., et al., Potential of mixed tocotrienol supplementation to reduce cholesterol and cytokines level in adults with metabolic syndrome. Mal J Nutr, 2015. 22(2): p. 231-243.
    6. Ng, Y.T., et al., The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial. Nutrients, 2020. 12(5).
    7. Chuar, P.F., et al., Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial. Nutrients, 2021. 13(11).
    8. Qureshi, A.A., et al., The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem, 1986. 261(23): p. 10544-50.
    9. Pearce, B.C., et al., Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem, 1992. 35(20): p. 3595-606.
    10. Song, B.L. and R.A. DeBose-Boyd, Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem, 2006. 281(35): p. 25054-61.
    11. Qureshi, A.A., et al., Dose-dependent modulation of lipid parameters, cytokines, and RNA by delta-tocotrienol in hypercholesterolemic subjects restricted to AHA Step-1 diet. Brit J of Med & Med Res, 2015. 6(4): p. 351-366.
    12. Qureshi, A.A., et al., Impact of delta-tocotrienol on inflammatory biomarkers and oxidative stress in hypercholesterolemic subjects. Clin. Exp. Cardiology, 2015. 6(4): p. 1000367.
    13. Grundy, S.M., Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol, 2012. 59(7): p. 635-43.
    14. Suleman, F., et al., Effects of delta-tocotrienol supplementation on glycaemic control in individuals with prediabetes: A randomized controlled study. J Pak Med Assoc, 2022. 72(1): p. 4-7.
    15. Mahjabeen, W., et al., Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial. Phytother Res, 2021.
    16. Qureshi, A.A., et al., A Novel Mixture of δ-Tocotrienol, Vitamin D3, Resveratrol (NS-3) Significantly Decreases Diabetes Biomarkers Including Inflammatory in People with Type 2 Diabetes. J Diab Clin Stud, 2021. 5(1).
    17. Pervez, M.A., et al., Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Turk J Gastroenterol, 2018. 29(2): p. 170-176.
    18. Pervez, M.A., et al., Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Comp Ther Med, 2020. 52: p. 102494.
    19. El Hadi, H., R. Vettor, and M. Rossato, Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? Antioxidants (Basel), 2018. 7(1).
    Related Searches
    • Vitamins
    • Inflammation
    • Research
    • Diabetes & Blood Sugar Management
    Related Knowledge Center
    • Inflammation
    • Antioxidants
    • Diabetes & Blood Sugar Management
    • Cardiovascular Health
    • Healthy Aging
    • Vitamins
    • Research
    Suggested For You
    SGS SGS
    Dyna-Tabs, LLC Dyna-Tabs, LLC
    Artificial Sweetener Intake Linked to Higher Body Fat Volume Artificial Sweetener Intake Linked to Higher Body Fat Volume
    Clinical Study to Commence on Migraines and Vitamin K2 Clinical Study to Commence on Migraines and Vitamin K2
    WHO Advises Against Non-Sugar Sweeteners for Weight Loss WHO Advises Against Non-Sugar Sweeteners for Weight Loss
    Entrinsic Bioscience Unveils Animal Study on Breakthrough Hydration Technology Entrinsic Bioscience Unveils Animal Study on Breakthrough Hydration Technology
    Building on Steps to Improve Children’s Health Around the World Building on Steps to Improve Children’s Health Around the World
    Aging in America Aging in America
    Harmonizing the EU Harmonizing the EU's Upper Limits For Micronutrients
    Sonoran University of Health Sciences: Lifelong Learning of Nature’s Healing Power Sonoran University of Health Sciences: Lifelong Learning of Nature’s Healing Power
    All Eyes on Vision Health All Eyes on Vision Health
    Soft Gel Technologies, Inc. Soft Gel Technologies, Inc.
    Top Sports Nutrition Trends That Reach Athletes and Everyday Consumers Top Sports Nutrition Trends That Reach Athletes and Everyday Consumers
    Foodarom Group Inc. Foodarom Group Inc.
    Marinova Pty Ltd Marinova Pty Ltd

    Related Buyers Guide Companies

    • SGS

      SGS

      ...
      Michelle Lee, Marketing Analyst 09.28.23

    • Dyna-Tabs, LLC

      ...
      HAROLD BAUM, MANAGING DIRECTOR 09.26.23

    • Breaking News | Functional Foods & Beverages | Research | Research News | Sweeteners | Weight Management/Weight Loss
      Artificial Sweetener Intake Linked to Higher Body Fat Volume

      Artificial Sweetener Intake Linked to Higher Body Fat Volume

      A 20-year observational study linked aspartame, saccharin, and diet beverages, but not sucralose, to greater volumes of body fat.
      08.09.23


    • Breaking News | Dietary Supplements | Research | Research News | Vitamins
      Clinical Study to Commence on Migraines and Vitamin K2

      Clinical Study to Commence on Migraines and Vitamin K2

      The new six-month trial will be conducted by Gnosis by Lesaffre in conjunction with Omicron Pharmaceuticals.
      07.21.23

    • Breaking News | Functional Foods & Beverages | Healthcare Trends | Industry & Market News | Sweeteners | Weight Management/Weight Loss
      WHO Advises Against Non-Sugar Sweeteners for Weight Loss

      WHO Advises Against Non-Sugar Sweeteners for Weight Loss

      The organization cited a review which found no benefit for reducing body fat, but an association with mortality risk.
      05.22.23

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    • New Technology Converts Sugar In Juice To Fiber
    Breaking News
    • D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    • Natrol Launches First Non-Melatonin Sleep Supplement
    • Metagenics Releases Consumer Survey on Menopausal Support Supplement
    • Culturelle Probiotics Launches Women’s Health Awareness Campaign
    • Women's Health Brand O Positiv Launches Essentials Line of Supplements
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    BASF Donates $5,000 to High School STEAM Education Programs in Chattanooga Area
    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    ScentAir Debuts Room Sprays & More
    African Pride Launches On-Campus Activations
    Sharper Image Debuts Revel Hair Tools
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI's LLT grows, Labelexpo Europe details big numbers and more
    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Thomas Receives INDA Lifetime Technical Service Award, ExxonMobil Works with JL Goor
    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login